In situ forming implants - An attractive formulation principle for parenteral depot formulations

Journal of Controlled Release

Volumn 161, Issue 2, 2012, Pages 668-679

  Kempe, Sabine ^a   Mäder, Karsten ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Biodegradable; Controlled release; Implants; In situ; Parenteral; Polymer

Indexed keywords

BIODEGRADABLE; BURST RELEASE; CLINICAL TRIAL; CONTROLLED RELEASE; CONTROLLED RELEASE FORMULATIONS; DRUG RELEASE; IN-SITU; IN-SITU FORMING; IN-VIVO; MICRO-PARTICLES; ORGANOGELS; PARENTERAL; TISSUE RESPONSE; USED PRODUCT; VISCOUS SOLUTION;

DEGRADATION; DENTAL PROSTHESES; PHASE SEPARATION; POLYMERS; TISSUE;

BIODEGRADABLE POLYMERS;

ALGINIC ACID; BUPIVACAINE; CHITOSAN; CYCLOSPORIN A; DOXORUBICIN; DOXYCYCLINE HYCLATE; DRUG CARRIER; ETHINYLESTRADIOL PLUS LEVONORGESTREL; INSULIN; LEUPRORELIN; PACLITAXEL; POLOXAMER; POLYMER; RISPERIDONE; RIVASTIGMINE;

ADULT DISEASE; ADVANCED CANCER; ALZHEIMER DISEASE; BIPOLAR DISORDER; CANCER ADJUVANT THERAPY; CHEMICAL COMPOSITION; CHEMICAL MODIFICATION; CHEMICAL STRUCTURE; CLINICAL TRIAL (TOPIC); CONTROLLED DRUG RELEASE; CROSS LINKING; DRUG DELIVERY SYSTEM; DRUG EFFICACY; ESOPHAGUS CANCER; HYDROGEL; IN SITU FORMING IMPLANT; NONHUMAN; PERIODONTITIS; PH; PHASE TRANSITION; POLYMERIZATION; POSTOPERATIVE PAIN; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; SCHIZOPHRENIA; SEPARATION TECHNIQUE; SUSTAINED DRUG RELEASE; SYNTHESIS; VISCOSITY;

ANIMALS; DRUG IMPLANTS; GELS; HUMANS; INFUSIONS, PARENTERAL;

EID: 84862652505     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2012.04.016     Document Type: Review

References (154)

1. R. Mank, G. Rafler, B. Nerlich, Parenterale Depotarzneiformen auf der Basis von biologisch abbaubaren Polymeren, Phamazie 46 (1991) 9-17.
2. S. Tamilvanan, Oil-in-water lipid emulsions: implications for parenteral and ocular delivering systems, Prog. Lipid Res. 43 (2004) 489-533.
3. A. Sharma, U.S. Sharma, Liposomes in drug delivery: progress and limitations, Int. J. Pharm. 154 (1997) 123-140.
4. A.N. Lukyanov, V.P. Torchilin, Micelles from lipid derivatives of water-soluble polymers as delivery systems for poorly soluble drugs, Adv. Drug Deliv. Rev. 56 (2004) 1273-1289.
5. S. Thatte, K. Datar, R.M. Ottenbrite, Perspectives on: polymeric drugs and drug delivery systems, J. Bioact. Compat. Polym. 20 (2005) 585-601.
6. S. Freiberg, X.X. Zhu, Polymer microspheres for controlled drug release, Int. J. Pharm. 282 (2004) 1-18.
7. P. Couvreur, C. Vauthier, Nanotechnology: intelligent design to treat complex disease, Pharm. Res. 23 (2006) 1-34.
8. Y.S Rhee, C.M. Park, P.P. DeLuca, H.M. Monsour, Sustained-release injectable drug delivery systems, Pharm. Tech. (Nov 1 2010) s6-s13.
9. S.S. Lee, P. Hughes, A.D. Ross, M.R. Robinson, Biodegradable implants for sustained drug release in the eye, Pharm. Res. 27 (2010) 2043-2053.
10. C. Wischke, S.P. Schwendeman, Principles of encapsulating hydrophobic drugs in PLA/PLGA microparticles, Int. J. Pharm. 364 (2008) 298-327.
11. E. Ruel-Gariepy, J.C. Leroux, In situ-forming hydrogels - review of temperature-sensitive systems, Eur. J. Pharm. Biopharm. 58 (2004) 409-426.
12. A. Hatefi, B. Amsden, Biodegradable injectable in situ forming drug delivery systems, J. Control. Release 80 (2002) 9-28.
13. C.B. Packhaeuser, J. Schnieders, C.G. Oster, T. Kissel, In situ forming parenteral drug delivery systems: an overview, Eur. J. Pharm. Biopharm. 58 (2004) 445-455.
14. A. Gutowska, B. Jeong, M. Jasionowski, Injectable gels for tissue engineering, Anat. Rec. 263 (2001) 342-349.
15. M.K. Joo, M.H. Park, B.G. Choi, B. Jeong, Reverse thermogelling biodegradable polymer aqueous solutions, J. Mater. Chem. 19 (2009) 5891-5905.
16. A.K. Burkoth, K.S. Anseth, A review of photocrosslinked polyanhydrides: in situ forming degradable networks, Biomaterials 21 (2000) 2395-2404.
17. S.Y. Lee, G. Tae, Formulation and in vitro characterization of an in situ gelable, photo-polymerizable Pluronic hydrogel suitable for injection, J. Control. Release 119 (2007) 313-319.
18. J. Berger, M. Reist, J.M. Mayer, O. Felt, N.A. Peppas, R. Gurny, Structure and interactions in covalently and ionically crosslinked chitosan hydrogels for biomedical applications, Eur. J. Pharm. Biopharm. 57 (2004) 19-34.
19. F.L. Mi, S.S. Shyu, T.B. Wong, S.F. Jang, S.T. Lee, K.T. Lu, Chitosan-polyelectrolyte complexation for the preparation of gel beads and controlled release of anticaner drug. II. Effect of pH-dependent ionic crosslinking or interpolymer complex using triphosphate or polyphosphate as reagent, J. Appl. Polym. Sci. 74 (1999) 1093-1107.
20. K.S. Anseth, S.M. Newman, C.N. Bowman, Polymeric dental composites: properties and reaction behavior of multimethacrylate dental restorations, Biopolymers 122 (1995) 177-217.
21. J.A. Burdick, L.M. Philpott, K.S. Anseth, Synthesis and characterization of tetrafunctional lactic acid oligomers: a potential in situ forming degradable orthopaedic biomaterial, J. Polym. Sci. A Polym. Chem. 39 (2001) 683-692.
22. J.A. Burdick, R.F. Padera, J.V. Huang, K.S. Anseth, An investigation of the cytotoxicity and histocompartibility of in situ forming lactic acid based orthopedic biomaterials, J. Biomed. Mater. Res. 63 (2002) 484-491.
23. A.S. Sawhney, C.P. Pathak, J.J. Van Rensburg, R.C. Dunn, J.A. Hubbell, Optimization of photopolymerized bioerodible hydrogel properties for adhesion prevention, J. Biomed. Mater. Res. 28 (1994) 831-838.
24. M.D. Lyman, D. Melanson, A.S. Sawhney, Characterization of the formation of interfacially photopolymerized thin hydrogels in contact with arterial tissue, Biomaterials 17 (1996) 359-364.
25. B. Balakrishnan, A. Jayakrishnan, Self-cross-linking biopolymers as injectable in situ forming biodegradable scaffolds, Biomaterials 26 (2005) 3941-3951.
26. T. Vermonden, N.E. Fedorovich, D. Van Gemen, J. Alblas, C.F. van Nostrum, W.J.A. Dhert, W.E. Hennink, Photopolymerized thermosensitive hydrogels: synthesis, degradation, and cytocompatibility, Biomacromolecules 9 (2008) 919-926.
27. J.B. Leach, C.E. Schmidt, Characterization of protein release from photocrosslinkable hyaluronic acid-polyethylene glycol hydrogel tissue engineering scaffolds, Biomaterials 26 (2005) 125-135.
28. K. Ono, Y. Saito, H. Yura, K. Ishikawa, Photocrosslinkable chitosans a biological adhesive, J. Biomed. Mater. Res. A 49 (2000) 289-295.
29. M. Ishihara, K. Obara, S. Nakamura, M. Fujita, K. Masuoka, B. Kanatani, H. Takase, Y. Hattori, M. Morimoto, T. Ishihara, T. Maehara, M. Kikuchi, Chitosan hydrogel as a drug delivery carrier to control angiogenesis, J. Artif. Organs 9 (2006) 8-16.
30. L. Pescosolido, Interpenetrating polymer network hydrogels based on polysaccharides for biomedical applications, 20-6-2011, University of Utrecht
31. X.Z. Shu, K.J. Zhu, W. Song, Novel pH-sensitive citrate cross-linked chitosan film for drug controlled release, Int. J. Pharm. 212 (2001) 19-28.
32. M. Hamdine, M.C. Heuzey, A. Begin, Viscoelastic properties of phosphoric and oxalic acid-based chitosan hydrogels, Rheologica Acta 45 (2006) 659-675.
33. J. Berger, M. Reist, O. Felt, R. Gurny, Structure and interactions in chitosan hydrogels formed by complexation or aggregation for biomedical applications, Eur. J. Pharm. Biopharm. 57 (2004) 35-52.
34. M.T. Nickerson, J. Patel, D.V. Heyd, D. Rousseau, A.T. Paulson, Kinetic and mechanistic considerations in the gelation of genipin-crosslinked gelation, Int. J. Biol. Macromol. 39 (2006) 298-302.
35. T.R. Hoare, D.S. Kohane, Hydrogels in drug delivery, Polymer 49 (2008) 1993-2007.
36. A. Bernkop-Schurch, M. Hornof, T. Zoidl, Thiolated polymers-thiomers: synthesis and in vitro evaluation of chitosan-2-iminothiolane conjugates, Int. J. Pharm. 260 (2003) 229-237.
37. A.H. Krauland, V.M. Leitner, A. Bernkop-Schurch, Improvement of the in situ gelling properties of deacytylated gellan gum by the immobilization of thiol groups, J. Pharm. Sci. 92 (2003) 1234-1241.
38. A. Bernkop-Schurch, A.H. Krauland, V.M. Leitner, Thiomers: potential excipients for non-invasive peptide delivery systems, Eur. J. Pharm. Biopharm. 58 (2004) 253-263.
39. K. Kafedjiiski, R.K.R. Jetti, F. Föger, H. Hoyer, M. Werle, M. Hoffer, A. Bernkop-Schurch, Synthesis and in vitro evaluation of thiolated hyaluronic acid for mucoadhesive drug delivery, Int. J. Pharm. 343 (2007) 48-58.
40. B. Qui, S. Stefanos, J. Ma, A. Lalloo, B.A. Perry, M.J. Leibowitz, P.J. Sinko, S. Stein, A hydrogel prepared by in situ cross-linking of a thio-containing poly(ethylene glycol)-based copolymer: a newbiomaterial for protein drug delivery, Biomaterials 24 (2002) 11-18.
41. B. Balakrishnan, M. Mohanty, P.R. Umashankar, A. Jayakrishnan, Evaluation of an in situ forming hydrogel wound dressing based on oxidized alginate and gelatin, Biomaterials 26 (2005) 6335-6342.
42. A. Vintiloui, J.C. Leroux, Organogels and their use in drug delivery - a review, J. Control. Release 125 (2008) 179-192.
43. A. Vintiloui, M. Lafleur, G. Bastiat, J.C. Leroux, In situ-forming oleogel implant for rivastigmine delivery, Pharm. Res. 25 (2008) 845-852.
44. F. Plourde, A. Motulsky, A.C. Couffin-Hoarau, D. Hoarau, H. Ong, J.C. Leroux, First report on the efficacy of L-alanine-based in situ-forming implants for the long-term parenteral delivery of drugs, J. Control. Release 108 (2005) 433-441.
45. Z.H. Gao, A.J. Shukla, J.R. Johnson, W.R. Crowley, Controlled release of contraceptive steroids from biodegradable and injectable gel formulation - in vivo evaluation, Pharm. Res. 12 (1995) 864-868.
46. A.R. Ahmed, A. Dashevsky, R. Bodmeier, Drug release form and sterilization of in situ cubic phase forming monoglyceride drug delivery systems, Eur. J. Pharm. Biopharm. 75 (2010) 375-380.
47. M.N.V.R. Kumar, R.A.A. Muzzarelli, C. Muzzarelli, H. Sashiwa, A.J. Domb, Chitosan chemistry and pharmaceutical perspectives, Chem. Rev. 104 (2004) 6017-6084.
48. R. Joshi, D.H. Robinson, K.J. Himmelstein, In vitro properties of an in situ forming gel for the parenteral delivery of macromolecular drugs, Pharm. Dev. Technol. 4 (1999) 515-522.
49. P.E. Alonso, L.A. Perula, L.F. Rioja, Pain-temperature relation in the application of local anaesthesia, Br. J. Plast. Surg. 46 (1993) 76-78.
50. J. Heller, J. Barr, S.Y. Ng, H.R. Shen, K. Schwach-Abdellaoui, S. Einmahl, A. Rothen-Weinhold, R. Gurny, Poly(ortho esters) - their development and some recent applications, Eur. J. Pharm. Biopharm. 50 (2000) 121-137.
51. S. Einmahl, K. Schwach-Abdellaoui, J. Heller, R. Gurny, Poly(ortho esters): recent developments for biomedical applications, Chimia 55 (2001) 218-222.
52. S. Einmahl, S. Capancioni, K. Schwach-Abdellaoui, M. Moeller, F. Behar-Cohen, R. Gurny, Therapeutic applications of viscous and injectable poly(ortho esters), Adv. Drug Deliv. Rev. 53 (2001) 45-73.
53. R.S. Bezwada, S.C. Arnold, Liquid absorbable copolymers for parenteral applications, Patent [5653992], 5-8-1997.
54. Y. Liu, W.L. Lu, J.C. Wang, X. Zhang, H. Zhang, X.Q. Wang, T.Y. Zhou, Q. Zhang, Controlled delivery of recombinant hirudin based on thermo-sensitive Pluronic® F127 hydrogel for subcutaneous administration: in vitro and in vivo characterization, J. Control. Release 117 (2007) 387-395.
55. A. Sosnik, D. Cohn, J.S. San Roman, G.A. Abraham, Crosslinkable PEO-PPO-PEO-based reverse thermo-responsive gels as potentially injectable materials, J. Biomater. Sci. Polym. Ed. 14 (2003) 227-239.
56. A. Sosnik, D. Cohn, Reverse thermo-responsive poly(ethylene oxide) and poly(propylene oxide) multiblock copolymers, Biomaterials 26 (2005) 349-357.
57. F. Tirnaksiz, J.R. Robinson, Rheological, mucoadhesive and release properties of Pluronic F-127 gel and Pluronic F-127/polycarbophil mixed gel systems, Pharmazie 60 (2005) 518-523.
58. D.C. Coughlan, O.I. Corrigan, Drug-polymer interactions and their effect on thermoresponsive poly(N-isopropylacrylamide) drug delivery systems, Int. J. Pharm. 313 (2006) 163-174.
59. B. Jeong, S.W. Kim, Y.H. Bae, Thermosensitive sol-gel reversible hydrogels, Adv. Drug Deliv. Rev. 54 (2002) 37-51.
60. B. Jeong, A. Gutowska, Lessons from nature: stimuli-responsive polymers and their biomedical applications, Trends Biotechnol. 20 (2002) 305-311.
61. H. Hyun, Y.H. Kim, I.B. Song, J.W. Lee, M.S. Kim, G. Khang, K. Park, H.B. Lee, In vitro and in vivo release of albumin using a biodegradableMPEG-PCL diblock copolymer as an in situ gel-forming carrier, Biomacromolecules 8 (2007) 1093-1100.
62. G.M. Zentner, R. Rathi, J.C. Shih, J.C. McRea, M.H. Seo, H. Oh, B.G. Rhee, J. Mestecky, Z. Moldoveana, M. Morgan, S. Weiman, Biodegradable block copolymers for delivery of proteins and water insoluble drugs, J. Control. Release 72 (2001) 203-215.
63. http://www.btgplc.com/page/12921/btg-plc-close-period-update: assessed 20. January 2012, A. Burrows, BTG Press Release - Close period update, 05-04-2011, London (UK).
64. Y.M. Chung, K.L. Simmons, A. Gutowska, B. Jeong, Sol-gel transition temperature of PLGA-g-PEG aqueous solutions, Biomacromolecules 3 (2002) 511-516.
65. B. Jeong, L.Q. Wang, A. Gutowska, Biodegradable thermoreversible gelling PLGA-g-PEG copolymers, Chem. Commun. (2001) 1516-1517.
66. K. Mäder, B. Gallez, K.J. Liu, H.M. Swartz, Non-invasive in vivo characterization of release processes in biodegradable polymers by low-frequency electron paramagnetic resonance spectroscopy, Biomaterials 17 (1996) 457-461.
67. A.G. Ding, A. Shenderova, S.P. Schwendeman, Prediction of microclimate pH in poly(lactic-co-glycolic acid) films, J. Am. Chem. Soc. 128 (2006) 5384-5390.
68. J.Y. Lee, K.S. Kim, Y.M. Kang, E.S. Kim, S.J. Hwang, H.B. Lee, B.H. Min, J.H. Kim, M.S. Kim, In vivo efficacy of paclitaxel-loaded injectable in situ-forming gel against subcutaneous tumor growth, Int. J. Pharm. 392 (2010) 51-56.
69. Y.M. Kang, G.H. Kim, J.I. Kim, D.Y. Kim, B.N. Lee, S.M. Yoon, J.H. Kim, M.S. Kim, In vivo efficacy of an intratumorally injected in situ-forming doxorubicin/poly-(ethylene glycol)-b-polycaprolactone diblock copolymer, Biomaterials 32 (2011) 4556-4564.
70. K. Kobayashi, C. Huang, T.P. Lodge, Thermoreversible gelation of aqueous methylcellulose solutions, Macromolecules 32 (1999) 7070-7077.
71. D. Gupta, C.H. Tator, M.S. Shoichet, Fast-gelling injectable blend of hyaluronan and methylcellulose for intrathecal, localized delivery to the injured spinal cord, Biomaterials 27 (2006) 2370-2379.
72. A. Chenite, C. Chaput, D. Wang, C. Combes, M.D. Buschmann, C.D. Hoemann, J.C. Leroux, B.L. Atkinson, F. Binette, A. Selmani, Novel injectable neutral solutions of chitosan form biodegradable gels in situ, Biomaterials 21 (2000) 2155-2161.
73. E. Ruel-Gariepy, A. Chenite, C. Chaput, S. Guirguis, J.C. Leroux, Characterization of thermosensitive chitosan gels for the sustained delivery of drugs, Int. J. Pharm. 203 (2000) 89-98.
74. E. Ruel-Gariepy, M. Shive, A. Bichara, M. Berrada, D. Le Garrec, A. Chenite, J.C. Leroux, A thermosensitive chitosan-based hydrogel for the local delivery of paclitaxel, Eur. J. Pharm. Biopharm. 57 (2004) 53-63.
75. E. Ruel-Gariepy, G. Leclair, P. Hildgen, A. Gupta, J.C. Leroux, Thermosensitive chitosan-based hydrogel containing liposomes for the delivery of hydrophilic molecules, J. Control. Release 82 (2002) 373-383.
76. M. Iliescu, C.D. Hoemann, M.S. Shive, A. Chenite, M.D. Buschmann, Ultrastructure of hybrid chitosan-glycerolphosphate blood clots by environmental scanning electron microscopy, Microsc. Res. Tech. 71 (2008) 236-247.
77. C. LeDuc, J. Benarrosh, BioSyntech 2007 Annual Report, 20-7-2007, Laval (Canada), Biosyntech
78. D. Steinberg, M. Friedman, Dental drug delivery devices: local and sustained release applications, Crit. Rev. Ther. Drug Carrier Syst. 16 (1999) 425-459.
79. O. Sator, M.K. Dineen, R. Perez-Marreno, F.M. Chu, G.J. Carron, R.C. Tyler, An eight-month clinical study of LA-2575 30.0 mg: a new 4-month, subcutaneous delivery system for leuprolide acetate in the treatment of prostate cancer, Urology 62 (2003) 319-323.
80. R.L. Dunn, A.J. Tipton, G.L. Southard, J.A. Rogers, Biodegradable polymer composition, US Patent [5599552], 1997.
81. G. Chandrashekar, N. Udupa, Biodegradable injectable implant system for long term drug delivery using poly (lactic-co-glycolic) acid copolymers, J. Pharm. Pharmacol. 48 (1996) 669-674.
82. Y. Tang, J. Singh, Controlled delivery of aspirin: effect of aspirin on polymer degradation an in vitro release from PLGA based phase sensitive systems, Int. J. Pharm. 357 (2008) 119-125.
83. H.B. Ravivarapu, K.L. Moyer, R.L. Dunn, Sustained activity and release of leuprolide acetate from an situ forming polymeric implant, AAPS Pharm. Sci. Technol. 1 (2000) article 1.
84. W.J. Lambert, K.D. Peck, Development of an in situ forming biodegradable polylactide-co-glycolide system for the controlled release of proteins, J. Control. Release 33 (1995) 189-195.
85. K.J. Brodbeck, S. Pushpala, A.J. Mchugh, Sustained release of human growth hormone from PLGA solution depots, Pharm. Res. 16 (1999) 1825-1829.
86. R. Eliaz, J. Kost, Characterization of a polymeric PLGA-injectable implant delivery system for the controlled release of proteins, J. Biomed. Mater. Res. 50 (2000) 388-396.
87. M. Dittgen, S. Fricke, H. Gerecke, I.P. Möller, C. Völkel, Injection Implant, PCT/DE1997/002903[WO/1998/030245], 1998, Germany
88. A. McHugh, The role of polymer membrane formation in sustained release drug delivery systems, J. Control. Release 109 (2005) 211-221.
89. W.Y. Dong, M. Körber, V. Lopez Esguerra, R. Bodmeier, Stability of poly(D, L-lactide-co-glycolide) and leuprolide acetate in-situ forming drug delivery systems, J. Control. Release 115 (2006) 158-167.
90. X. Luan, R. Bodmeier, Influence of the poly(lactide-co-glycolide) type on the leuprolide release from in situ forming microparticle systems, J. Control. Release 110 (2006) 266-272.
91. P.D. Graham, K.J. Brodbeck, A.J. McHugh, Phase inversion dynamics of PLGA solutions related to drug delivery, J. Control. Release 58 (1999) 233-245.
92. K.J. Brodbeck, J.R. DesNoyer, A.J. McHugh, Phase inversion dynamics of PLGA solutions related to drug delivery - part II. The role of solution thermodynamics and bath-side mass transfer, J. Control. Release 62 (1999) 333-344.
93. N.H. Shah, A.S. Railkar, F.C. Chen, R. Tarantino, S. Kumar, M. Murjani, D. Palmer, M.H. Infeld, A.W. Malick, A biodegradable injectable implant for delivering micro and macromolecules using poly(lactic-co-glycolic) acid (PLGA) copolymers, J. Control. Release 27 (1993) 139-147.
94. F. Kang, J. Singh, In vitro release of insulin and biocompatibility of in situ forming gel systems, Int. J. Pharm. 304 (2005) 83-90.
95. Y. Lu, Y. Yu, X. Tang, Sucrose acetate isobutyrate as an in situ forming system for sustained risperidone release, J. Pharm. Sci. 96 (2007) 3252-3262.
96. F. Okumu, L. Dao, P. Fielder, N. Dybdal, D. Brooks, S. Sane, J. Cleland, Sustained delivery of human growth hormone froma novel gel system: SABER™, Biomaterials 23 (2002) 4353-4358.
97. M.A. Royals, S.M. Fujita, G.L. Yewey, J. Rodriguez, P.C. Schultheiss, R.L. Dunn, Biocompatibility of a biodegradable in situ forming implant system in rhesus monkeys, J. Biomed. Mater. Res. 45 (1999) 231-239.
98. H. Kranz, G.A. Brazeau, J. Napaporn, R.L. Martin, W. Millard, R. Bodmeier, Myotoxicity studies of injectable biodegradable in-situ forming drug delivery systems, Int. J. Pharm. 212 (2001) 11-18.
99. W. Rungseevijitprapa, G.A. Brazeau, J.W. Simkins, R. Bodmeier, Myotoxicity studies of O/W-in situ forming microparticle systems, Eur. J. Pharm. Biopharm. 69 (2008) 126-133.
100. H. Kranz, R. Bodmeier, A novel in situ forming drug delivery system for controlled parenteral drug delivery, Int. J. Pharm. 332 (2007) 107-114.
101. M. Voigt, Biodegradable non-aqueous in situ forming microparticle drug delivery systems, 2011, FU Berlin
102. K. Schoenhammer, H. Petersen, F. Guethlein, A. Goepferich, Poly(ethyleneglycol) 500 dimethylether as novel solvent for injectable in situ forming depots, Pharm. Res. 26 (2009) 2568-2577.
103. S. Kempe, Non-invasive characterization of in situ forming implants, 2012, Martin-Luther-University Halle-Wittenberg
104. E. Pamula, E. Menaszek, In vitro and in vivo degradation of poly(l-lactide-co-glycolide) films and scaffolds, J. Mater. Sci. Mater. Med. 19 (2008) 2063-2070.
105. A. Lochmann, H. Nitzsche, A. Schädlich, S. von Einem, E. Schwarz, K. Mäder, Applicability testing of in situ forming implants with incorporated microspheres: in vivo monitoring of calcification, Regen. Med. 4 (2009) 5218-5219.
106. R.V. Contri, T. Katzer, A.R. Pohlmann, S.S. Guterres, Chitosan hydrogel containing capsaicinoids-loaded nanocapsules: an innovative formulation for topical delivery, Soft Mater. 8 (4) (2010) 370-385.
107. S. Dong, S. Wang, C. Zheng, W. Liang, Y. Hunag, An in situ-forming, solid lipid/PLGA hybrid implant for long-acting antipsychotics, Soft Matter 7 (2011) 5873-5878.
108. H. Liu, S.S. Venkatraman, Cosolvent effects on the drug release and depot swelling in injectable in situ depot-forming systems, J. Pharm. Sci. 101 (2012) 1783-1793.
109. D. Kapoor, O.P. Katare, S. Dhawan, In situ forming implant for controlled delivery of an anti-HIV fusion inhibitor, Int. J. Pharm. 426 (2012) 132-143.
110. A. Mashak, H. Mobedi, F. Ziaee, M. Nekoomanesh, The effect of aliphatic esters on the formation and degradation behaviour of PLGA-based in situ forming systems, Polym. Bull. 66 (2011) 1063-1073.
111. X. Lin, S. Yang, J. Gou, M. Zhao, Y. Zhang, N. Qi, H. He, C. Cai, X. Tang, P. Guo, A novel risperidone-loaded SAIB-PLGA mixtures matrix depot with a reduced burst release: effect of solvents and PLGA on drug release behaviors in vitro/in vivo, J. Mater. Sci. Mater. Med. 23 (2012) 443-455.
112. Y. Liu, A. Kemmer, K. Keim, C. Curdy, H. Petersen, T. Kissel, Poly(ethylene carbonate) as a surface-eroding biomaterial for in situ forming parenteral drug delivery systems: a feasibility study, Eur. J. Pharm. Biopharm. 76 (2010) 222-229.
113. L.W. Wang, S. Venkatraman, L. Kleiner, Drug release from injectable depots: two different in vitro mechanisms, J. Control. Release 99 (2004) 207-216.
114. R. Astaneh, M. Erfan, H. Moghimi, H. Mobedi, Changes in morphology of in situ forming PLGA implant prepared by different polymer molecular weight and its effect on release behaviour, J. Pharm. Sci. 98 (2009) 135-145.
115. K. Wang, Q. Jia, J. Yuan, S. Li, A novel, simple method to simulate gelling process of injectable biodegradable in situ forming drug delivery system based on determination of electrical conductivity, Int. J. Pharm. 404 (2011) 176-179.
116. S. Kempe, H. Metz, K. Mäder, Application of electron paramagnetic resonance (EPR) spectroscopy and imaging in drug delivery research - chances and challenges, Eur. J. Pharm. Biopharm. 74 (2010) 55-66.
117. S. Kempe, H. Metz, P.G.C. Pereira, K. Mäder, Non-invasive in vivo evaluation of in situ forming PLGA implants by benchtop magnetic resonance imaging (BT-MRI) and EPR spectroscopy, Eur. J. Pharm. Biopharm. 74 (2010) 102-108.
118. S. Kempe, H. Metz, K. Mäder, Do in situ forming PLG/NMP implants behave similar in vitro and in vivo? A noninvasive and quantitative EPR investigation on the mechanism of the implant formation process, J. Control. Release 130 (2008) 220-225.
119. S. Kempe, H. Metz, M. Bastrop, A. Hvilsom, R.V. Contri, K. Mäder, Characterisation of thermosensitive chitosan-based hydrogels by rheology and electron paramagnetic resonance spectroscopy, Eur. J. Pharm. Biopharm. 68 (2008) 26-33.
120. B. Madhu, I. Elmroth, A. Lundgren, B. Abrahamsson, B. Soussi, A novel evaluation of subcutaneous formulations by in vivo magnetic resonance imaging (MRI), Pharm. Res. 45 (2002) 207-212.
121. L. Solorio, B.M. Babin, R.B. Patel, J. Mach, N. Azar, A.A. Exner, Noninvasive characterization of in situ forming implants using diagnostic ultrasound, J. Control. Release 143 (2010) 183-190.
122. R.B. Patel, L. Solorio, H. Wu, T. Krupka, A.A. Exner, Effect of injection site on in situ implant formation and drug release in vivo, J. Control. Release 147 (2010) 350-358.
123. K. Mäder, B. Gallez, K.J. Liu, H.M. Swartz, Non-invasive in vivo characterization of release processes in biodegradable polymers by low-frequency electron paramagnetic resonance spectroscopy, Biomaterials 17 (4) (1996) 457-461.
124. H. Kranz, E. Yilmaz, G.A. Brazeau, R. Bodmeier, In vitro and in vivo drug release from a novel in situ forming drug delivery system, Pharm. Res. 25 (2008) 1347-1354.
125. D. Klose, F. Siepmann, K. Elkharraz, J. Siepmann, PLGA-based drug delivery systems: importance of the type of drug and device geometry, Int. J. Pharm. 354 (2011) 95-103.
126. N. Faisant, J. Akiki, F. Siepmann, J.P. Benoit, J. Siepmann, Effects of the type of release medium on drug release from PLGA-based microparticles: experiment and theory, Int. J. Pharm. 314 (2006) 189-197.
127. D. Klose, C. Delplace, J. Siepmann, Unintended potential of perfect sink conditions on PLGA degradation in microparticles, Int. J. Pharm. 404 (2011) 75-82.
128. K. Schoenhammer, H. Petersen, F. Guethlein, A. Goepferich, Injectable in situ forming depot systems: PEG-DAE as novel solvent for improved PLGA storage stability, Int. J. Pharm. 371 (2009) 33-39.
129. T. Trimaille, R. Gurny, M. Möller, Poly(hexyl-substituted lactides): novel injectable hydrophobic drug delivery systems, J. Biomed. Mater. Res. A 80A (2007) 55-65.
130. L.R. Asmus, R. Gurny, M. Moller, Solutions as solutions - synthesis and use of a liquid polyester excipient to dissolve lipophilic drugs and formulate sustained-release parenterals, Eur. J. Pharm. Biopharm. 79 (2011) 584-591.
131. L.R. Asmus, R. Gurny, M. Moller, Solutions for lipophilic drugs: a biodegradable polymer acting as solvent, matrix, and carrier to solve drug delivery issues, Int. J. Artif. Organs 34 (2011) 238-242.
132. L. Klouda, A.G. Mikos, Thermoresponsive hydrogels in biomedical applications, Eur. J. Pharm. Biopharm. 68 (2008) 34-45.
133. E.A. Ho, V. Vassileva, C. Allen, M. Piquette-Miller, In vitro and in vivo characterization of a novel biocompatible polymer-lipid implant system for the sustained delivery of paclitaxel, J. Control. Release 104 (2005) 181-191.
134. A. Kikuchi, T. Okano, Pulsatile drug release control using hydrogels, Adv. Drug Deliv. Rev. 54 (2002) 53-77.
135. H. Dai, Q. Chen, H.L. Qin, Y. Guan, D.Y. Shen, Y.Q. Hua, Y.L. Tang, J. Xu, A temperature-responsive copolymer hydrogel in controlled drug delivery, Macromolecules 39 (2006) 6584-6589.
136. P. Gerentes, L. Vachoud, J. Doury, A. Domard, Study of a chitin-based gel as injectable material in periodontal surgery, Biomaterials 23 (2002) 1295-1302.
137. P. Roughley, C. Hoemann, E. Desrosiers, F. Mwale, J. Antoniou, M. Alini, The potential of chitosan-based gels containing intervertebral disc cells for nucleus pulposus supplementation, Biomaterials 27 (2006) 388-396.
138. F. Ganji, M.J. Abdekhodaie, A. Ramazani, Gelation time and degradation rate of chitosan-based injectable hydrogel, J. Sol-Gel Sci. Technol. 42 (2007) 47-53.
139. J. Li, Z. Xu, Physical characterization of a chitosan-based hydrogel delivery system, J. Pharm. Sci. 91 (2007) 1669-1677.
140. E. Ruel-Gariepy, J.C. Leroux, Chitosan: a natural polycation with multiple applications, Polysaccharides Drug Deliv. Pharm. Appl. 934 (2006) 243-259.
141. J. Berger, A. Reist, A. Chenite, O. Felt-Baeyens, J.M. Mayer, R. Gurny, Pseudo-thermosetting chitosan hydrogels for biomedical application, Int. J. Pharm. 288 (2005) 197-206.
142. A. Chenite, M. Buschmann, D. Wang, C. Chaput, N. Kandani, Rheological characterisation of thermogelling chitosan/glycerol-phosphate solutions, Carbohydr. Polym. 46 (2001) 39-47.
143. R. Ahmadi, J.D. deBruijn, Biocompatibility and gelation of chitosan-glycerolphosphate hydrogels, J. Biomed. Mater. Res. A 86 (2008) 824-832.
144. K.E. Crompton, J.D. Goud, R.V. Bellamkonda, T.R. Gengenbach, D.I. Finkelstein, M.K. Horne, J.S. Forsythe, Polylysin-functionalised thermoresponsive chitosan hydrogel for neutral tissue engineering, Biomaterials 28 (2007) 441-449.
145. J. Sun, G. Jiang, T. Qui, Y. Wang, K. Zhang, F. Ding, Injectable chitosan-based hydrogel for implantable drug delivery: body response and induced variations of structure and composition, J. Biomed. Mater. Res. A 95A (2010) 1019-1027.
146. J. Moura, H. Faneca, M.P. Lima, M.H. Gil, M.M. Figueiredo, In situ forming chitosan hydrogels prepared via ionic/covalent co-cross-linking, Biomacromolecules 12 (2011) 3275-3284.
147. Y.B. Schuetz, R. Gurny, O. Jordan, A novel thermoresponsive hydrogel based on chitosan, Eur. J. Pharm. Biopharm. 68 (2008) 19-25.
148. R. Mulik, V. KulKarni, R.S.R. Murthy, Chitosan-based thermosensitive hydrogel containing liposomes for sustained delivery of cytarabine, Drug Dev. Ind. Pharm. 35 (2009) 49-56.
149. M.H. Cho, K.S. Kim, H.H. Ahn, M.S. Kim, S.H. Kim, G. Khang, B. Lee, H.B. Lee, Chitosan gel as an in situ-forming scaffold for rat bone marrow mesenchymal stem cells in vivo, Tissue Eng. Part A 14 (2008) 1099-1108.
150. C. Hoemann, J. Sun, A. Légaré, M.D. McKee, M. Buschmann, Tissue engineering of cartilage using an injectable and adhesive chitosan-based cell-delivery vehicle, Osteoarthritis Cartilage 13 (2005) 318-329.
151. T. Kean, M. Thanou, Biodegradation, biodistribution and toxicity of chitosan, Adv. Drug Deliv. Rev. 62 (2010) 3-11.
152. T.A. Khan, K.K. Peh, H.S. Ch'ng, Reporting degree of deacetylation values of chitosan: the influence of analytical methods, J. Pharm. Sci. 5 (2002) 205-212.
153. C. Augsten, K. Mäder, Characterizing molar mass distributions and molecule structures of different chitosans using asymmetrical flow field-flow fractionation combined with multi-angle light scattering, Int. J. Pharm. 351 (2008) 23-30.
154. W. Wang, L. Chang, X. Li, Y. Wu, J. Xing, L. Deng, A. Dong, Controlled thermal gelation of poly(ε-caprolactone)/poly(ethylene glycol) block copolymers by modifying cyclic ether pedant groups on poly(ε-caprolactone), Soft Matter 8 (2012) 1575-1583.